15 August 2017
15 August 2017
Redelease is introducing the semi-permanent mould release Ycon CR8, developed by UK company Marbocote, to the Brazilian composites market.
Ycon CR8 is said to combine excellent performance with ease of application.
“Ycon CR8 quickly reacts on the surface of the mould, preparing it for use in a shorter time compared to competing products," reports Roberto Iacovella, Managing Partner of Redelease. "This faster reaction speed also prevents an operator from being allocated just to remove excess product from the mould, a common practice when other semi-permanent mould release agents are applied.”
According to Iacovella, tests conducted in the UK demonstrated that 1 litre of Ycon CR8 can cover, after the application of four layers, 20-25 square metres of surface.
“This is a better performance than the products currently available in Brazil,” he says.
Ycon CR8 is the first product developed by Marbocote exclusively for the Brazilian market.
“In one year of partnership with Redelease, we have identified many business opportunities in the country," notes Ian Snowdon, Director of Marbocote. "That is why we decided to invest in a formulation that would meet the key requirements of local composite manufacturers.”
Redelease introduced the concept of semi-permanent mould release of composite parts to Brazil in 1997. Unlike the traditional carnauba wax, which demands a new coat at each release, the semi-permanent agents ensure multiple mould releases. This increases speeds up production and reduces damage to the mould.
Photo provided by Redelease
The Latin American Composite Materials Association (ALMACO) is organising the event Pultrusion – Innovations, Solutions and Trends at the Petrobras Research Center (CENPES) in Rio de Janeiro, Brazil, on 23 August.
Project 12 has collaborated with Total Composite Solutions (TCS), the UK partner of Microtex, on automotive OEM projects for bespoke carbon parts.
Continental Structural Plastics (CSP) will install a sheet moulding compound (SMC) production line at its facility in Pouance, France, to support the need for its composite formulations in Europe.